ZERO WORLD RESEARCHアミノ酸・有機酸の学術文献データベース

Body fat percentage is a key factor in elevated plasma levels of caffeine and its metabolite in women.

体脂肪率は女性におけるカフェインとその代謝物の血漿濃度上昇の主要因子である (機械翻訳の邦題)

PeerJ2025Domaszewski P, Konieczny M, Pakosz P, et al.
研究デザインその他の原著論文
対象ヒト

記録の確認項目

研究デザイン
その他の原著論文
対象
ヒト
出版年
2025
出典
doi.org
抄録の表示
表示あり
出版状態
有効な記録
状態確認日
2026/08/17
収集日
2026/08/03
鮮度
確認期限内
確認段階
自動処理
記録状態
公開

日本語要約(機械生成)

本研究は、女性における体脂肪率とカフェインおよびその代謝物の血漿濃度との関連を検討した。対象は38人の女性で、体脂肪率に基づき非肥満群(14人)と肥満群(24人)に分類した。両群に体重当たり6mg/kgのカフェインを投与し、60分後に血漿中のカフェイン、パラキサンチン、テオブロミン濃度を測定した。その結果、肥満群では非肥満群に比べ、カフェインとパラキサンチンの濃度が有意に高かったが、テオブロミンには有意差はなかった。また、カフェイン濃度は脂肪量と強い正の相関を示した。これらの結果から、体脂肪率は体重よりもカフェイン代謝に重要な因子であり、個別化されたカフェイン投与量の指標となる可能性が示唆された。

この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。

抄録

Background: Caffeine (CAF) intake is measured in absolute daily amounts or doses per kilogram of body weight. However, both methods are not entirely appropriate. The activity of liver enzymes that metabolise caffeine may be reduced in obese individuals, and plasma caffeine concentrations may vary depending on the fat-to-free-fat mass ratio. This study investigates the relationship between, between body fat percentage and the plasma concentrations of caffeine and its metabolites in women.Methods: This experimental study with a between-group comparison design included 38 women (age 25.5 ± 2.7 years; body weight 66.5 ± 15.3 kg). Body fat percentage was measured using bioimpedance analysis (mBCA 515 SECA analyzer), and participants were categorized as non-obese (≤30% body fat, n = 14) or obese (>30% body fat, n = 24). Both groups received a dose of 6 mg/kg body weight of caffeine. Blood samples were taken 60 min after caffeine ingestion, and the concentrations of caffeine and its metabolites in plasma were determined by high-pressure liquid chromatography. The Mann-Whitney U test assessed CAF, paraxanthine (PX), and theobromine (TB) concentrations, while Spearman's correlation analyzed variable relationships. General linear model (GLM) compared caffeine metabolite levels, and GPower determined the required sample size (44) for large effects.Results: The results showed that the obese group had significantly higher caffeine (Mdn = 10.64 vs. Mdn = 2.32) and PX concentrations (Mdn = 1.73 vs. Mdn = 0.85) compared to the non-obese group, with significant differences (p < 0.001 and p = 0.007, respectively). However, no significant difference in TB concentration was observed (p = 0.486). A linear model revealed that group membership significantly influenced CAF concentration (p < 0.001), explaining 56.8% of its variance. PX and TB concentrations showed poor model fits, with minimal explanatory power from group, age, fat mass, and body mass index (BMI). Correlation analysis found strong associations between CAF concentration and fat mass (rho = 0.689).Conclusions: Higher body fat percentage is associated with increased plasma caffeine and paraxanthine concentrations following a weight-based caffeine dose. These findings suggest that body fat percentage may be a more relevant factor than total body weight in caffeine metabolism, with potential implications for personalized caffeine dosing guidelines.

MeSH

Adipose TissueAdultBody CompositionCaffeineCentral Nervous System StimulantsChromatography, LiquidDose-Response Relationship, DrugElectric ImpedanceFemaleHumansLinear ModelsObesityStatistics, NonparametricTheobromineTheophyllineYoung Adult

DOI 10.7717/peerj.19480

PMID 40511376

原文・出典を見る →